| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
2 companies
Spa Essetifin last filed a Form 4 in April 2020, as 10% Owner at FENC. The filings on record cover 2 companies. Spa Essetifin's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,993,694 shares of FENC. Net of sales, the FENC filings show accumulation of 1,062,115 shares.
Spa Essetifin has 3 Form 4 filings on record from November 2017 to April 2020, across 2 companies: 10% Owner at Fennec Pharmaceuticals (FENC), 2017–2020; Former 10% Owner at Soligenix (SNGX), 2017.
The 8 reported transactions were 5 open-market purchases and 3 open-market sales.
Counted by filing, the open-market trades come to 3 purchases worth about $7.9M and 1 sale worth about $622K.
The largest open-market purchase was 768,000 shares of FENC at an average $6.25 on April 30, 2020, about $4.8M.
The only open-market sale was 293,510 shares of SNGX at an average $2.12 on November 29, 2017, about $622K.
Shares as reported in the last Form 4 for each company; the most recent is from April 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2020 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 768,000 | $6.25 | $4,800,000.00 | +23.8% | |
| Dec 12, 2017 | FENC Fennec Pharmaceuticals Inc. | 10% Owner | Buy | 294,115 | $8.50 | $2,499,977.50 | +10.0% | |
| Nov 29, 2017 | SNGX Soligenix, Inc. | Former 10% Owner | Buy | 293,510 | $2.12 | $622,241.20 | New | |
| Nov 29, 2017 | SNGX Soligenix, Inc. | Former 10% Owner | Sell | 293,510 | $2.12 | $622,241.20 | -100% |